Guidance and quality standards In consultation
Showing 1 to 5 of 5
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive B-precursor acute lymphoblastic leukaemia with no measurable residual disease ID6405 | Draft scope consultation | Health technology evaluation | |
Selpercatinib for advanced thyroid cancer with RET alterations that has not been treated with systemic therapy [ID6132] | Draft guidance | Technology appraisal guidance | |
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic device | Diagnostics consultation | Diagnostics guidance | |
Novel home-testing devices for diagnosing obstructive sleep apnoea/hypopnoea syndrome | Diagnostics consultation | Diagnostics guidance | |
Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A [ID6170] | Draft guidance | Technology appraisal guidance |